Literature DB >> 16433680

CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27.

Shinji Kagami1, Hidehisa Saeki, Mayumi Komine, Takashi Kakinuma, Koichiro Nakamura, Yuichiro Tsunemi, Kiyo Sasaki, Akihiko Asahina, Kunihiko Tamaki.   

Abstract

Both CCL27 and CCL28 are ligands for CCR10 and attract CCR10(+) lymphocytes. We previously demonstrated that CCL27 and CCL28 were strongly expressed in sera and lesional keratinocytes of patients with atopic dermatitis and psoriasis vulgaris. However, the regulation of CCL27 and CCL28 production in keratinocytes has not been well documented. In this study, we showed that CCL27 and CCL28 expression and production by a human keratinocyte cell line, HaCaT cells, were strongly induced by inflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta. CCL27 production was downregulated by inhibitors of p38 mitogen-activated protein kinase and nuclear factor-kappa B (NF-kappaB). By contrast, CCL28 production was downregulated by inhibitors of extracellular signal-regulated kinase and NF-kappaB. Our study results suggest that CCL28 produced by keratinocytes is mediated by different signal pathways from CCL27 and that both CCL27 and CCL28 are involved in the pathogenesis of inflammatory skin diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433680     DOI: 10.1111/j.1600-0625.2005.00390.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

Review 1.  CCR10 and its ligands in regulation of epithelial immunity and diseases.

Authors:  Na Xiong; Yaoyao Fu; Shaomin Hu; Mingcan Xia; Jie Yang
Journal:  Protein Cell       Date:  2012-06-08       Impact factor: 14.870

2.  CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.

Authors:  Xiao Li Yang; Kai Yi Liu; Feng Juan Lin; Hui Min Shi; Zhou Luo Ou
Journal:  Oncol Rep       Date:  2017-07-07       Impact factor: 3.906

3.  CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.

Authors:  Shanmugapriya Thangavadivel; Claudia Zelle-Rieser; Angelika Olivier; Benno Postert; Gerold Untergasser; Johann Kern; Andrea Brunner; Eberhard Gunsilius; Rainer Biedermann; Roman Hajek; Ludek Pour; Wolfgang Willenbacher; Richard Greil; Karin Jöhrer
Journal:  Oncotarget       Date:  2016-11-29

Review 4.  CCL27 Signaling in the Tumor Microenvironment.

Authors:  Miguel Martínez-Rodríguez; Carlos Monteagudo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IκB.

Authors:  Deok-Soo Son; Syder M Kabir; Yuan-Lin Dong; Eunsook Lee; Samuel E Adunyah
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

6.  Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation.

Authors:  Alí Alejo; M Begoña Ruiz-Argüello; Sergio M Pontejo; María Del Mar Fernández de Marco; Margarida Saraiva; Bruno Hernáez; Antonio Alcamí
Journal:  Nat Commun       Date:  2018-05-03       Impact factor: 17.694

7.  Polyopes affinis Suppressed IFN-γ- and TNF-α-Induced Inflammation in Human Keratinocytes via Down-Regulation of the NF-κB and STAT1 Pathways.

Authors:  Yuna Ha; Won-Hwi Lee; Jang Kyun Kim; Hee-Kyung Jeon; Jongsung Lee; Youn-Jung Kim
Journal:  Molecules       Date:  2022-03-11       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.